Ginkgo Bioworks Holdings (DNA) Interest & Investment Income (2020 - 2021)
Ginkgo Bioworks Holdings posted quarterly Interest & Investment Income of $496000.0 for Q4 2021, up 116.63% year-on-year from $228964.4 in Q4 2020, and up 309.92% on a QoQ basis from $121000.0 in Q3 2021.
Ginkgo Bioworks Holdings (DNA) has 2 years of Interest & Investment Income data on file, last reported at $496000.0 in Q4 2021.
- For the quarter ending Q4 2021, Interest & Investment Income rose 116.63% year-over-year to $496000.0; the trailing twelve-month figure through Dec 2021 stood at $952000.0 (changed N/A YoY), and the FY2025 full-year result was $22.6 million, down 41.43% from the prior year.
- Interest & Investment Income for Q4 2021 stood at $496000.0, up from $121000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.3 million in Q3 2020 and bottomed at -$3.0 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 496,000.00 |
| Sep 30, 2021 | 121,000.00 |
| Dec 31, 2020 | -2.98 Mn |
| Sep 30, 2020 | 3.32 Mn |